Drug recall · February 9, 2022
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg recall
Why: Mislabeling
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42
- Lots / codes
Lot#: 100018610, Exp 03/2022; 100021521, Exp 09/2022; 100024575, Exp 01/2023
- Quantity
- 6430 cartons
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- USA Nationwide
- Initiated
- January 7, 2022 · Voluntary: Firm initiated
- Classified
- February 2, 2022
- Reported
- February 9, 2022
- Ended
- June 1, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol / norethindrone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.